Want to see VSEE full AI Analyst Report?
VSEE Stock Chart & Stats
$0.08
>-$0.01(-1.27%)
At close: 4:00 PM EDT
$0.08
>-$0.01(-1.27%)
Day’s Range― - ―
52-Week Range<$0.01 - $2.52
Previous Close$0.08
Volume3.12M
Average Volume (3M)1.90M
Market Cap
$1.56M
Enterprise Value$7.77
Total Cash (Recent Filing)$454.15K
Total Debt (Recent Filing)$1.88M
Price to Earnings (P/E)―
Beta0.51
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding56,679,813
10 Day Avg. Volume5,577,105
30 Day Avg. Volume1,899,699
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.38
Price to Sales (P/S)0.52
P/FCF Ratio-2.17
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Manageable Reported LeverageReported leverage is moderate relative to equity, giving VSee some balance-sheet flexibility despite losses. This provides a more stable base for restructuring operations or funding growth if cash generation improves.
Recurring Digital Health ModelA subscription and enterprise-contract model can create recurring revenue and deepen customer workflow integration. RPM deployments and software services may support retention and expansion when providers scale virtual-care programs.
Liability Reduction Through DivestitureThe VSee Lab divestiture removes the subsidiary’s post-closing liabilities and cancels a substantial insider-held share position. Although legacy tax liabilities remain, the transaction may simplify the group and reduce ongoing balance-sheet exposure.
Bears Say
Shrinking Revenue And Deep LossesDeclining revenue combined with a cost base far above the current sales level shows that VSee has not yet achieved operating leverage. Persistent losses could limit investment capacity and make a durable return to profitability difficult.
Persistent Cash BurnThe core business is consuming cash rather than financing operations, increasing dependence on external capital. Continued burn could force additional borrowing or equity issuance, limiting strategic flexibility and increasing shareholder dilution risk.
Delisting And Trading Suspension RiskA Nasdaq suspension and potential delisting would weaken market access, investor visibility, and the company’s ability to use listed equity as financing. The unresolved compliance issue also signals persistent governance and capital-markets risk.
VSee Health News
VSEE FAQ
What was VSee Health’s price range in the past 12 months?
VSee Health lowest stock price was <$0.01 and its highest was $2.52 in the past 12 months.
What is VSee Health’s market cap?
VSee Health’s market cap is $1.56M.
When is VSee Health’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were VSee Health’s earnings last quarter?
Currently, no data Available
Is VSee Health overvalued?
According to Wall Street analysts VSee Health’s price is currently Overvalued.
Does VSee Health pay dividends?
VSee Health does not currently pay dividends.
What is VSee Health’s EPS estimate?
VSee Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VSee Health have?
VSee Health has 56,679,813 shares outstanding.
What happened to VSee Health’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of VSee Health?
Currently, no hedge funds are holding shares in VSEE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
VSee Health
VSee Health, Inc. specializes in delivering virtual healthcare solutions. Their flagship offering, iDoc Telehealth, is specifically designed to manage and coordinate comprehensive care for severely ill individuals within various critical care environments, including neurointensive, cardiac intensive, and general intensive care units (ICUs). This system addresses complex conditions such as stroke, spinal cord injuries, brain trauma, and other severe neurological disorders. Beyond specialized care, their broader telehealth platform provides a modular suite of digital tools, empowering clients to customize solutions to their unique needs. VSee Health, Inc. is headquartered in Newton, Massachusetts.
Technical Analysis
Ownership Overview
9.72% Insiders
0.49% Mutual Funds
7.22% Other Institutional Investors
82.19% Public Companies and
Individual Investors